Suppr超能文献

在开具阿片类药物处方的老年人中,疼痛未缓解以及阿片类药物使用障碍或过量的风险。

Unrelieved pain and risk of opioid use disorder or overdose in older adults prescribed opioids.

作者信息

Wei Yu-Jung Jenny, Schmidt Siegfried, Fillingim Roger B, Brock Guy, Schmidt Stephan, Winterstein Almut G

机构信息

Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, United States.

Department of Community Health and Family Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.

出版信息

Pain. 2025 Mar 18. doi: 10.1097/j.pain.0000000000003589.

Abstract

It is unclear to what extent unrelieved pain, the most common motive for prescription opioid misuse, is associated with risks of opioid use disorder (OUD) and opioid overdose (OD) among older adults with prescribed opioids. This retrospective cohort study was conducted among Health and Retirement Study (HRS) participants with linked Medicare claims data between 2006 and 2021. Participants aged 65 years or older with chronic pain who had received at least 1 opioid prescription entered the cohort in an HRS-assessed pain assessment (index) between 2008 and 2020. We included 2 time-varying measures of HRS-assessed pain exposure: uncontrolled pain, defined as having moderate or severe pain, and high-impact pain, defined as having moderate to severe pain that impacted daily activities. Primary outcomes of incident OUD or OD diagnosis were analyzed using separate Cox regression models with marginal structural modeling. Of 3104 eligible participants identified, 1359 (43.8%) had uncontrolled pain and 1044 (33.6%) experienced high-impact pain in the index wave. In the marginal structural modeling-adjusted Cox regression model, patients with uncontrolled (vs controlled) pain had higher risks of OUD (adjusted hazard ratio [AHR] 9.70; 95% confidence interval [CI], 4.56-20.63) and OD (AHR 2.46; 95% CI 1.30-4.66). The AHR for OUD was 6.74 (95% CI 3.76-12.08) and for OD was 1.96 (95% CI 1.07-3.60) times higher for patients with vs without high-impact pain. Our findings underscore the importance of regular assessment and modification of pain management for older patients whose pain remains unrelieved after opioid treatment, to lower the risk of OUD and OD.

摘要

在开具阿片类药物的老年人中,未缓解的疼痛是处方阿片类药物滥用最常见的动机,目前尚不清楚其在多大程度上与阿片类药物使用障碍(OUD)和阿片类药物过量(OD)风险相关。这项回顾性队列研究是在健康与退休研究(HRS)参与者中进行的,这些参与者在2006年至2021年期间有相关的医疗保险理赔数据。年龄在65岁及以上、患有慢性疼痛且至少接受过1次阿片类药物处方的参与者,于2008年至2020年期间在HRS评估的疼痛评估(指数)中进入队列。我们纳入了2种HRS评估的疼痛暴露的时变测量指标:未控制的疼痛,定义为有中度或重度疼痛;以及高影响疼痛,定义为有中度至重度疼痛且影响日常活动。使用带有边际结构模型的单独Cox回归模型分析了OUD或OD诊断事件的主要结局。在3104名符合条件的参与者中,1359名(43.8%)在指数波中有未控制的疼痛,1044名(33.6%)经历了高影响疼痛。在边际结构模型调整的Cox回归模型中,有未控制(与已控制)疼痛的患者发生OUD的风险更高(调整后的风险比[AHR]为9.70;95%置信区间[CI],4.56 - 20.63),发生OD的风险也更高(AHR为2.46;95% CI为1.30 - 4.66)。有高影响疼痛的患者与没有高影响疼痛的患者相比,发生OUD的AHR为6.74(95% CI为3.76 - 12.08),发生OD的AHR为1.96(95% CI为1.07 - 3.60)。我们的研究结果强调了对阿片类药物治疗后疼痛仍未缓解的老年患者进行定期疼痛管理评估和调整的重要性,以降低OUD和OD的风险。

相似文献

7
Opioids for cancer pain - an overview of Cochrane reviews.用于癌症疼痛的阿片类药物——Cochrane系统评价综述
Cochrane Database Syst Rev. 2017 Jul 6;7(7):CD012592. doi: 10.1002/14651858.CD012592.pub2.
10
Hydromorphone for cancer pain.氢吗啡酮用于癌症疼痛。
Cochrane Database Syst Rev. 2016 Oct 11;10(10):CD011108. doi: 10.1002/14651858.CD011108.pub2.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验